AOD-9604
Coming soonhGH fragment 176-191Synthetic peptide made of the C-terminal fragment of human growth hormone, residues 177 to 191, with an added N-terminal tyrosine and a disulfide bridge. Researchers study it in rodent models and in analytical detection work.
Supplied as a single-chamber lyophilized vial with a colour-coded cap (Weight Regulation).
Research literature, not dosing or treatment instructions.
- The metabolic actions of AOD9604 were studied in Zucker rats, including changes in adipose tissue. (PMID 11146367)
- A rodent study examined the beta-adrenergic pathway and lipid metabolism after exposure to human growth hormone or AOD9604. (PMID 11713213)
Add the solvent slowly along the vial wall; swirl gently, never shake. Allow to dissolve fully. Six-step guide with photos →
Concentration calculator only. Enter the mass being calculated; blend components are not added automatically. Products are for in-vitro research.
Refer to the product label and supplier documentation for storage conditions. Lot-specific storage and expiry information is not available here.
Each certificate is published with its lot number.
Questions about AOD-9604
How much published research is there on AOD-9604?
The research library's PubMed search for AOD-9604 returned 23 records on 5 October 2026, 9 of them reviews. The library lists 3 studies chosen for what they measured. ClinicalTrials.gov lists no registered study naming AOD-9604 (checked 5 October 2026).
Is AOD-9604 an approved medicine?
No centrally authorised medicine containing AOD-9604 is listed in the EMA medicines database (checked 5 October 2026), and the research material we supply is not a medicine. It is supplied for in-vitro laboratory research only, not for human or veterinary use.
Which part of growth hormone is AOD-9604?
Residues 177 to 191 of human growth hormone, with an added N-terminal tyrosine and a disulfide bridge. The literature also writes the fragment as hGH 176-191.
How is the identity of AOD-9604 confirmed on a certificate?
A research-grade certificate of analysis typically reports identity by mass spectrometry and purity by HPLC. The mass result is read against the average molecular weight of 1815.1 Da listed on this page. The research library's guide to reading a certificate explains each field.
What other names is AOD-9604 published under?
AOD-9604 is also written hGH fragment 176-191 and AOD 9604. The catalog lists it under the name AOD-9604.
Is this product for human use?
No. Peptency products are supplied for in-vitro research only. Not for human or veterinary use, not for diagnosis or therapy.
Where can I find shipping information?
Current shipping rates and delivery information are on the Shipping & payment page, and the rates that apply to your order are shown at checkout.
Often studied with
For research use only. Not for human or veterinary use.
What is AOD-9604?
AOD-9604 is a synthetic peptide made of the C-terminal fragment of human growth hormone, amino acids 177 to 191, with an added N-terminal tyrosine and a disulfide bridge. Published work is limited to rodent studies and analytical detection. We supply AOD-9604 as a lyophilized vial for in-vitro laboratory research only.
What are the chemical identifiers of AOD-9604?
AOD-9604 has the molecular formula C78H123N23O23S2, an average molecular weight of 1815.1 Da and CAS number 221231-10-3.
Chemistry checked against PubChem (CID 71300630), 5 October 2026; full chemistry record in the research library.
What does published research on AOD-9604 cover?
A PubMed search for AOD-9604 returned 23 records on 5 October 2026, 9 of them reviews. Our research library lists 3 of these studies, chosen for what they measured.
- The metabolic actions of AOD9604 were studied in Zucker rats, including changes in adipose tissue. (Ng et al., Horm Res, 2000; PMID 11146367)
- A rodent study examined the beta-adrenergic pathway and lipid metabolism after exposure to human growth hormone or AOD9604. (Heffernan et al., Endocrinology, 2001; PMID 11713213)
Mechanism, every cited study and the regulator records are on the AOD-9604 page of the research library. Papers are listed by what they measured, not as evidence of any use.
How is AOD-9604 supplied and stored?
AOD-9604 is supplied as a lyophilized (freeze-dried) powder in a sealed vial, for in-vitro laboratory research only. Our stated storage condition for the sealed lyophilized vial is 2 to 8 °C. The label and the lot certificate carry the lot-specific storage condition and expiry date.
What is the regulatory status of AOD-9604?
The EMA medicines database (checked 5 October 2026) lists no centrally authorised medicine naming AOD-9604 (searched as AOD9604) as an active substance. National authorisations are not in that dataset.
No SmPC, PIL or PAR document in MHRA Products matches the exact name (checked 5 October 2026).
The WADA 2026 Prohibited List names this substance under S2.2.3. A WADA entry is a sporting rule, not a statement about legality outside sport.
A regulator record is information about a database entry. It is not advice and not a statement that any use is lawful or unlawful in any country. How regulators approach research peptides.
Which related research pages and compounds are listed?
Related compounds in the catalog: